Neurogenin 3 (Ngn3), a proneural gene, regulates dendritogenesis and synaptogenesis in mouse hippocampal neurons. Ngn3 is transiently exported from the cell nucleus to the cytoplasm when neuronal polarity is initiated, suggesting that the nucleo-cytoplasmic transport of the protein is important for its action on neuronal development. In this study, we identified for the first time a functional nuclear export sequence (NES2; 131 YIWALTQTLRIA 142 ) in Ngn3. The green fluorescent protein (EGFP)-NES2 fusion protein was localized in the cytoplasm and its nucleo-cytoplasmic shuttling was blocked by the CRM1 specific export inhibitor leptomycin B. Mutation of a leucine residue to alanine (L135A) in the NES2 motif resulted in both cytoplasmic and nuclear localization of the EGFP-NES2 fusion protein and in the nuclear accumulation of ectopic full-length myc-Ngn3. In addition, point mutation of the leucine 135 counteracted the effects of Ngn3 on neuronal morphology and synaptic inputs indicating that the cytoplasmic localization of Ngn3 is important for neuronal development. Pharmacological perturbation of the cytoskeleton revealed that cytoplasmic Ngn3 is associated with microtubules.
Introduction
Neurogenins (Ngn1, Ngn2 and Ngn3) are basic-helix-loop-helix (bHLH) proteins, which define a subfamily of atonal-related genes [1] [2] [3] . Ngn1 and Ngn2 function as proneural genes in the peripheral nervous system and thus promote both neurogenesis and notch-delta mediated lateral inhibition [4] . Ngn2 regulates neuronal subtype identity in the cerebral cortex, promoting glutamatergic cell fate [5, 6] . Ngn2 is also expressed in the progenitors that generate most dentate granule cells and has an essential role in the development of the dentate gyrus [7] .
Ngn3, the third member of the neurogenin family, is expressed in the embryonic pancreas as well as in the developing central nervous system [3, [8] [9] [10] . Ngn3 acts as a genetic switch that specifies an endocrine cell fate in pluripotent pancreatic [11] [12] [13] and intestinal progenitor [14, 15] . In the nervous system Ngn3 regulates gliogenesis in the developing vertebrate spinal cord [16] , neurogenesis in the retina [17] and neurogenesis and neuronal subtype specification in the hypothalamus [9] . Ngn3 is also involved in the regulation of neuronal development in the hippocampus. Overexpression of Ngn3 in cultured hippocampal neurons stimulates the outgrowth of new dendrites and induces an increase in the ratio of excitatory/inhibitory synaptic terminals [18, 19] . In addition, we have previously shown that Ngn3 is located not only in the cell nucleus but also in the perikaryon of hippocampal neurons. Furthermore, Ngn3 is transiently exported from the nucleus to the cytoplasm at critical periods of neuronal development, when neuronal polarity is established [10] , suggesting that nucleo-cytoplasmic shuttling of Ngn3 is important for the function of the protein. For that reason we have explored in this study the mechanism by which Ngn3 is exported from the cell nucleus.
In eukaryotes, the cell nucleus is separated from the cytoplasm by a nuclear membrane that contains nuclear pore complexes, which allow the transport of proteins and mRNAs across the nuclear envelope [20, 21] . This process requires the proteins importin or exportin [22, 23] . Importins and exportins form ternary complexes with Ran GTPase and recognize cargo proteins that bear specific nuclear localization sequences (NLS) and nuclear export sequences (NES), respectively. The majority of shuttling proteins described to date possess a leucine-rich type of NES similar to the one originally found in the HIV-1 Rev protein. This type of NES is known to be a target recognized by the exportin CRM1 [24] . The nuclear export of Rev protein is likely conducted by binding NES to the exportin CRM1, because the shuttling of the protein is inhibited by the CRM1 inhibitor leptomycin B (LMB). The complex can then translocate to the cytoplasm, where GTP is hydrolyzed to GDP, and the NES-containing protein is released. The exportin-RanGDP complex diffuses back to the nucleus where GDP is exchanged to GTP by Ran-guanine nucleotide exchange factors. This process is energy-dependent as it consumes one GTP per cycle. Some studies indicate that nucleocytoplasmic shuttling is a novel regulatory mechanism of proteins, which may participate in differentiation and in inhibition of cell death [25] . In this study we have identified a functional nuclear export sequence in Ngn3. In addition, a point mutation on this sequence blocks both the nucleo-cytoplasmic transport of Ngn3 as well as the effect of Ngn3 on neuronal morphology and synaptic inputs.
Results

Prediction of Ngn3 Nuclear Export Signals
Although it is well known that endogenous Ngn3 is localized predominantly in the cell nucleus [16, 26] , we have recently shown that Ngn3 also localizes in the perikarion of developing hippocampal neurons and that the nuclear export pathway utilized by Ngn3 is CRM1-dependent [10] . This pattern of subcellular localization led us to assess whether Ngn3 has a nuclear export signal. The simplest CRM1-dependent nuclear export determinants are the so-called classic nuclear export signals (NESs). These are short peptides comprising four spaced hydrophobic residues (denoted W 1 -W 4 ) and following the consensus
, where x is an amino acid preferentially negative charged, polar or small [27] . Therefore, we searched for NES sequences in Ngn3 and identified two potential NES motifs (NES1; 5 PLDALTIQVS 14 and NES2; 131 YIWALTQTLRIA 142 ) ( Figure 1 ). NES1 is not a perfect NES consensus because it has only one amino acid between the second and third hydrophobic residues. Also the NES1 has greater acidity consistent with the lower pI predicted using the ExPASy tool (ProtParam) (3.80 for NES1 versus 8.75 for NES2). Therefore NES2 is a more robust NES motif according with the consensus sequence and it is very well conserved in a variety of species ( Figure 1 ).
The NES2 of Ngn3 Determines a Cytoplasmic Localization and it is CRM1 Dependent
To establish whether these NESs can direct nuclear export, the two sequence fragments corresponding to putative NES1 or NES2 were cloned in pEGFP-C1 vector. Neuronal cultures were transfected with EGFP-NES1, EGFP-NES2 or EGFP expression vector at 2 DIV and examined by fluorescence microscopy. EGFP-NES1 was distributed in both the nucleus and the cytoplasm, like unmodified EGFP (Figure 2 , A, B and E). In contrast, cells expressing EGFP-NES2 showed mainly cytoplasmic fluorescence ( Figure 2, C and E) . Thus, the NES2, but not NES1, of Ngn3 is sufficient to direct the exclusion of the EGFP fusion constructs from the nucleus.
Leptomycin B (LMB), a specific inhibitor of the nuclear export receptor CRM1, prevents the CRM1-NES interaction, thus inducing the accumulation of shuttling proteins into the nucleus [28] . To determine whether the nuclear export of EGFP fused to NES1 and NES2 was CRM1 dependent, we examined the effect of LMB in the subcellular localization of EGFP-NES1 and EGFP-NES2. Fluorescence microscopy demonstrated that LMB did not affect the subcellular distribution of EGFP and EGFP-NES1 ( Figure 2E ). In contrast, LMB increased EGFP-NES2 accumulation in the cell nucleus ( Figure 2 , D and E). These observations suggested that the subcellular localization of EGFP-NES2 is regulated by CRM1. Therefore, we focused our next studies on NES2.
Mutational Analysis of NES2
To explore the repercussion of NES2 amino acid sequence on nuclear export activity, we generated point mutations within NES2 in which one leucine or isoleucine residues were replaced with alanine (I132A, L135A, L139A and I141A). The NE-S2L135A mutant showed a significant increase in the accumulation of NES2 in the cell nucleus, compared to wild-type NES2 ( Figure 3 , A-C). This demonstrates that the leucine 135 is the key amino acid to export the protein out of the nucleus. The subcellular localizations of EGFP-NES2L135A and EGFP-NE-S2L139A were not substantially affected by LMB treatment (Figure 3 C) suggesting that both leucines are important to bind NES2 to CRM1.
Mutation of the NES2 (L135A) Leads to Decreased Cytoplasmic Accumulation of Full-length Ngn3
To investigate the role of the NES2 in exporting full-length Ngn3, we determined the effect of mutating this export sequence on Ngn3 subcelluar localization. We used site-directed mutagenesis to generate an NES2-defective version of myc-Ngn3 (mycNgn3-L135A) in which leucine 135 was mutated to alanine. Primary neuronal cultures were transfected with plasmids expressing myc, wild-type myc-Ngn3 or myc-Ngn3-L135A and 24 h after transfection, indirect immunostaining of myc was used to detect the proteins (Figure 4 , A, B and C). Cells were cotransfected with EGFP to visualize their morphology (Figure 4 , D, E and F). In cells expressing myc-tag alone the fluorescence was distributed similarly between the nucleus and the cytoplasm, including the neurites (Figure 4 , A and G). In the case of wild-type myc-Ngn3, the myc fluorescence in the cytoplasm was relatively decreased in comparison to cells transfected with myc-tag alone, although significant cytoplasmic staining was detectable (Figure 4 , B and G). In contrast, cells expressing myc-Ngn3-L135A showed a strong decrease in myc cytoplasmic localization (Figure 4 , C and G). This was evident by the reduction in the myc labeling of the neurites, which were clearly visible with EGFP ( Figure 4, C and F) . Together, these results demonstrate that the NES2 reported here mediates Ngn3 nuclear export.
Mutation of the NES2 (L135A) Impairs the Effects of Ngn3 Overexpression on the Development of Hippocampal Neurons
To explore whether Ngn3 nucleo-cytoplasmic transport via CRM1 is involved in neuronal maturation, we performed a microscopic examination of dendritic processes and synaptogenesis in neuronal cultures at 4 DIV. Images in Figure 5 Figure 5G ) and an increase in the total number of synaptic terminals ( Figure 5H ). The change of leucine 135 by alanine in the Ngn3 sequence counteracts the effects of Ngn3 on the number of primary dendrites and the number of synaptic terminals. This suggests that the cytoplasmic localization of Ngn3 is important for its action on neuronal development.
Ngn3 Co-localizes with Microtubules but not with Actin Filaments in Hippocampal Neurons
A study of Ngn3 sequence carried with PSORT II Prediction program showed a moderate probability of cytoskeletal localization. This cue, together with the fact that we have demonstrated its localization and impact on dendrites, lead us to analyze if Ngn3 is associated with components of the cytoskeleton. By immunocytochemical assays of neurons permeabilized in PEM buffer (80 mM PIPES, 2 mM EGTA, 1 mM MgCl 2 , pH 6.8) containing 0.05% Triton X-100 to extract soluble cytosolic proteins, we found a colocalization of Ngn3 with tubulin ( Figure 6 , B-D, F) but not with actin filaments (Figure 6 , A, E), which were enriched in the growth cone of the cell processes ( Figure 6 F) .
To confirm the association between Ngn3 and microtubules, neuronal cultures were treated with paclitaxel (Taxol), a drug known to stabilize polymerized microtubules. The abundance of Ngn3 was monitored in the soluble and insoluble fractions of the cell lysates. As shown in Figure 7A , Ngn3 was enriched in the insoluble fraction. To correlate the localization of Ngn3 to the state of tubulin polymerization, the samples were also immunoblotted for bIII-tubulin. As expected, the treatment of the cultures with paclitaxel resulted in the enrichment of b-tubulin in the insoluble fraction ( Figure 7A ) corresponding to a stabilization of microtubules. In addition, the treatment of the cultures with paclitaxel resulted also in the enrichment of Ngn3 in the insoluble fraction ( Figure 7A ). Similar results were obtained in brain homogenates ( Figure 7B ). The treatment of brain homogenates with paclitaxel resulted in the enrichment of b-tubulin and Ngn3 in the insoluble fraction ( Figure 7B ). The interaction between soluble tubulin and Ngn3 was also observed by immunoprecipitation of the supernatants with anti-bIII-tubulin antibody and Western blotting of the precipitate with anti-Ngn3 antibody ( Fig. 7C) . Graphs in Figure 7 represent the relative amount of Ngn3 and the distribution of bIII-tubulin in the pellet and in the soluble fraction under the two experimental conditions tested in vivo and in vitro. Quantitative data are shown as the mean and standard error (s.e.m.) and statistical analyses was assessed using unpaired t-test. The levels of significance were denoted as *p,0.05, **p,0.01.
Discussion
The scientific question we are addressing deals with the mechanism by which Ngn3 is exported from the cell nucleus during hippocampal neuronal differentiation. In this work we have demonstrated that Ngn3 possesses a functional NES that is necessary for its translocation to the cytoplasm, where Ngn3 associates with microtubules and regulates neuronal differentiation. Our conclusion is based on three observations. First, the sequence between amino acids 131 and 142 (NES2) closely fit the consensus pattern of hydrophobic residue characteristics of NESs. Second, this sequence was able to mediate nuclear export of an EGFP fusion protein and the export was inhibited by treatment with LMB. Third, point mutation of the leucine 135 in this sequence abrogated export of EGFP-NES2 and myc-Ngn3 proteins and counteracted the effects of Ngn3 on neuronal morphology and synaptic inputs. The most characterized functional role of Ngn3 is its activity as a transcription factor in endocrine cells and accordingly Ngn3 is localized in the cell nucleus of different cell types [16, 26] . Recently we have reported that Ngn3 is also localized in the cytoplasm of hippocampal neurons during specific developmental stages. Ngn3 does not remain in the cytoplasm after being synthesized; it is first transported into the cell nucleus and then is exported out again to the cytoplasm, where it is localized in neuronal processes [10] . However, the mechanism for nuclear export of Ngn3 was unknown.
The NES Motif in the Ngn3 Sequence
Classic NESs are also referred to as leucine-rich NESs, but analyses of other export cargoes and randomization-and-selection screens showed that isoleucine, valine, methionine or phenylalanine are also permitted at the hydrophobic positions [29] [30] [31] . Searching for NES motif in Ngn3 sequences we identified two fragments that could function as NES according to published NES consensus sequences [32, 33] . Nevertheless only one of them, NES2, was able to direct the exclusion of the EGFP-NES2 fusion protein from the nucleus. The other one, NES1 did not exhibit nuclear export activity, probably because it do not fit as well as NES2 to the consensus sequence and also because it is a more acidic sequence than NES2. In addition, our findings suggest that the subcellular localization of EGFP-NES2 is regulated by CRM1, because the shuttling of the protein to the cytoplasm, as well as the shuttling of Ngn3, is inhibited by LMB [10] . Therefore, our data are compatible with an active nuclear export of Ngn3 mediated by an active NES located between amino acids 131 and 142.
Key Amino Acids to Bind NES2 to CRM1
To identify the specific amino acids that are responsible to bind NES2 to CRM1, the four hydrophobic amino acids were changed by alanine and its influence in the NES2 activity was studied. The mutations I132A and I141A were well tolerated when NES2 is fused to an exogenous reporter. The mutation L135A resulted in the loss of the NES2 ability to direct the EGFP-NES2 protein to the cytoplasm and in the loss of responsiveness to LMB treatment, indicating that the leucine 135 is crucial for the NES2 binding to CRM1. Interestingly, the mutation L139A did not change NES2 nuclear export activity but provoked the disappearance of the sensibility to LMB. This suggests that such amino acid collaborates in the NES2 binding to CRM1 and enhances NES function. In the case of full length Ngn3, the point mutation L135A of the mycNgn3 determines virtually only nuclear protein localization. Therefore we can conclude that leucine 135 is the main amino acid for the binding of Ngn3 to exportin and that Ngn3 translocation from the cell nucleus to the cytoplasm in neurons is mediated by the exportin CRM1. This is in concordance with previous data showing that Ngn3 is retained in the cytoplasm of multiple endocrine neoplasia type 1 islet and pancreatic endocrine tumor cells [34] and that tumor size is related with the level of CRM1 expression [35] .
It is of interest to note that L135A mutation had a stronger inhibitory effect on the nucleo-cytoplasmic transport of full length Ngn3 than on the nucleo-cytoplasmic transport of the NES2 fragment. The reason for this difference may be that Ngn3 has a nuclear localization site (NLS) while NES2 does not. Therefore, in the case of full-length protein the NLS promotes its translocation to the nucleus. This may also explain why in cells transfected with wild-type myc-Ngn3, the myc fluorescence in the cytoplasm was 
Functional Consequences of Ngn3 Nucleo-cytoplasmic Transport
The finding of Ngn3 shuttling between the cytoplasm and nucleus raises the question of whether this nucleo-cytoplasmic transport has a biological function. Other authors reported a patient with two heterozygous mutations in Ngn3 and a novel subtype of permanent neonatal diabetes associated with severe malabsorptive diarrhea. One of these mutation results in the substitution of leucine for proline at position 135. They also showed that electroporation with wild-type Neurogenin 3 provokes the differentiation of delaminating and hormone expressing cells outside the normal pancreas, whereas electroporation with Ngn3L135P had no detectable effect on the chicken endoderm [36] . We have found that L135A mutation, which reduces the nucelo-cytoplasmic transport of Ngn3, causes a decrease in the number of the primary dendrites and in the number of synaptic inputs. This finding suggests that nucleo-cytoplasmic translocation of Ngn3 during neuronal development [10] is involved in the initiation and growth of dendrites.
Ngn3 and the Cytoskeleton
The finding that the inhibition of nucleo-cytoplasmic transport of Ngn3 reduces dendritic development leads us to analyze whether Ngn3 may interact with components of the cytoskeleton. Immunocytochemical analyses showed that Ngn3 colocalizes with tubulin in cultured hippocampal neurons. The colocalization was detected in the perikaryon and the neuronal processes, including the growth cones. On the contrary, we did not detect colocalization of Ngn3 with actin filaments. In addition, Ngn3 increased in parallel with b-tubulin in the insoluble fraction of cell lysates from neuronal cultures or brain homogenates that were treated with paclitaxel to induce tubulin polymerization. Furthermore, the interaction of Ngn3 with tubulin was confirmed by immunopre- cipitation experiments. These findings suggest that Ngn3 is associated with microtubules. Canonical microtubule binding motifs are present in MAP and tau proteins [37] , but we have been unable to find such motifs in Ngn3. However, other proteins that lack canonical microtubule binding motifs, such as kinesins and myosins, are also able to associate to microtubules [38] [39] [40] . Furthermore, the interaction of Ngn3 with microtubules can be indirect and mediated by intermediate proteins. Therefore, our results suggest that the transient cytoplasmic accumulation of Ngn3 in developing neurons may mediate the actions of this molecule on the initiation of neuritogenesis.
Materials and Methods
Ethics Statement
CD1 mice were raised in the Cajal Institute and used to generate embryos for this study. The day of vaginal plug was defined as E0, and the mouse pups were born on E19 (P0). All procedures for handling and killing the animals used in this study were in accordance with the European Commission guidelines (86/609/CEE) and were approved by the Bioethics Committee of the ''Consejo Superior de Investigaciones Científicas'' (CSIC). Permit number: 28079/31A (01/18/2011).
Antibodies
The following primary antibodies were used: chicken anti-bIII tubulin (1:1000; Abcam, Cambridge, UK), mouse anti bIIItubulin (Tuj1; Covance, CA; 1:1000), mouse anti-synaptophysin I (1:500; Progen, Heidelberg, Germany), mouse anti-myc-tag (Roche, Indianapolis, IN, USA; 1:200), chicken anti-GFP (1:1000; Abcam, Cambridge, UK) and mouse anti-Ngn3 (F25A1B3; 1:2000) obtained from the NICHD Developmental Studies Hybridoma Bank (University of Iowa) with tyramide signal amplification (TSA and Cy3-TSA, PerkinElmer Life Sciences, Boston, MA) for immunostaining of Ngn3. To verify that the labelling was caused specifically by the primary antibodies, these were either omitted or replaced by similarly diluted normal serum from the same species. Peroxidase, biotin, FITC, Cy2, Cy3-conjugated secondary antibodies and peroxidase-conjugated streptavidin were from Jackson Immuno Research (West Grove, PA, USA) and Alexa 488-phalloidin (1:1000) was from Molecular Probes (Leiden, Holland).
Hippocampal Neuronal Cultures and Incubation Conditions
The hippocampus was dissected out from embryonic day 17 mouse embryos and dissociated to single cells after digestion with trypsin (Worthington Biochemicals, Freehold, NJ) and DNase I (Sigma-Aldrich, St. Louis, MO) [41] . Neurons were plated on 6-wells plates or glass coverslips coated with poly-L-lysine (SigmaAldrich) at a density of 300 neurons/mm 
Plasmid Constructs and Mutagenesis
For the construction of wild-type EGFP-NES1 and EGFP-NES2 constructs the following double-stranded oligonucleotides (Table 1) were annealed and ligated in the XhoI-EcoRI restriction sites of the expression vector pEGFP-C1 (Clontech, Palo Alto, CA).
Mutations of the EGFP-NES2 expression plasmid were created using the QuikChange II site-directed mutagenesis kit protocol, according to the manufacturer's specifications (Stratagene, La Jolla, CA). All PCR-generated clones were confirmed by sequencing. Primer sequences are specified in Table 2 .
Construction of the wild-type myc-Ngn3 expression plasmid (pCS2-myc-Ngn3) has been described previously [18] . The L135A mutation of Ngn3 was created directly in the pCS2-myc-Ngn3 construct using the QuikChange II site-directed mutagenesis kit. The primers used in this case are specified in Table 3 . All the plasmids were verified by DNA sequencing.
Transfection
Neurons were transfected at 3 DIV using the Effectene Transfection Reagent (Qiagen GmbH, Hilden, Germany), following the manufacturer's instructions. Cells were transfected Table 1 . Double-stranded oligonucleotides used for the construction of wild-type EGFP-NES1 and EGFP-NES2 constructs. Table 2 . Primer sequences used for construction of EGFP-NES2 mutants. with plasmids and after 16 h of expression time the cultures were fixed for immunostaining.
Microtubule Association Assays
To examine Ngn3-microtubule interaction in the cultures, cells were treated with paclitaxel (Taxol; 20 mM) for 40 minutes, homogenized in PEM buffer containing 0.05% Triton X-100 and protease inhibitors (Roche Diagnostics, Mannheim, Germany) and centrifuged at 4uC for 5 minutes at 10006g to eliminate the nucleus and membrane fractions. Supernatants were centrifuged at 4uC for 30 minutes at 100,0006g. The pellets (containing microtubules and associated proteins) were then directly depolymerized in SDS-PAGE sample buffer while soluble proteins were supplemented with 56 concentrated SDS-PAGE sample buffer. Both fractions were separated by SDS-PAGE, blotted and processed for immunodetection with anti-Ngn3 and anti-tubulin antibodies.
To examine Ngn3-microtubule interaction in vitro, embryonic mouse brains were homogenized in 10 volumes of PEM buffer containing 0.05% Triton X-100 and protease inhibitors, using 50 strokes in a glass-Teflon homogenizer. The homogenate was centrifuged at 16,0006g for 30 minutes at 4uC to eliminate the nuclear and membrane fractions and the supernatant was spun at 100,0006g for 30 minutes at 4uC. The resulting pellet was resuspended and divided in two. Aliquots were left untreated or treated with 20 mM paclitaxel (plus 1 mM GTP) for 40 minutes at RT. Aliquots were then centrifuged at 100,0006g for 30 minutes at 4uC. The pellet and supernatant fractions were then collected and analyzed by Western blotting.
Immunoprecipitation
The supernatants from the high speed centrifugation of the brain homogeates were incubated overnight with mouse anti-bIIItubulin antibody or with a not relevant mouse ascetic liquid at 4uC. Protein G agarose beads were then added and the incubation was maintained for 2 additional hours. The beads were washed extensively and boiled in the SDS loading buffer without reducing agent, and the precipitated proteins were detected by SDS-PAGE and Western blotting.
Western Blotting
Proteins were resolved by SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Millipore Ibérica, Madrid, Spain). The membranes were blocked in Tris-buffered saline containing 0.3% Tween 20 and 5% fat-free dry milk and incubated first with primary antibodies and then with horseradish peroxidase-conjugated secondary antibodies. Specific proteins were visualized with enhanced chemiluminescence detection reagent according to the manufacturer's instructions (Amersham, GE Healthcare Europe GmbH, Barcelona, Spain). Densitometry and quantification of the bands were carried out using the Quantity One software (Bio-Rad, Hercules, CA).
Image Acquisition and Analysis of Labelled Hippocampal Neurons
Images were acquired digitally using a 406 oil immersion objective and fluorescence filters. Confocal analysis was performed in a Leica (Bensheim, Germany) microscope. Photomicrographs were stored and digitally processed with Adobe Photoshop, v. 7.0 (Adobe Systems, San Jose, CA). Only minor adjustments to brightness and contrast were made. In order to quantify the Ngn3 nuclear localization signal by immunocytochemistry, randomly selected fields containing cells counterstained with DAPI were digitalized, and the Mean Gray Value for Ngn3 immunostaining in the nucleus and cytoplasm was measured using ImageJ 1.37 v software. The values were background subtracted using the average Mean Gray Value of the preparation background in each of the experimental conditions. Data were represented as relative fluorescence intensity of the cell nucleus versus the cytoplasm of each neuron. Primary dendrite number at 4 DIV (i.e., the number of dendrites emerging from the soma) and synaptic terminal counts were performed manually. A circular region of interest (ROI) with a diameter of 100 mm was projected onto the labeled neuron, its center roughly coinciding with the center of the soma. Synaptic terminals contacting the perikaryon or the dendrites were counted within the circular ROI. Dendrites broken at single or multiple points were defined as fragmented dendrites. Quantitative data are shown as the mean and standard error (mean+s. e. m.) from about 70 cells per experimental condition. Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, Inc., San Diego, CA). The one-way analysis of variance (ANOVA) was used for multiple statistical comparisons. When justified by the ANOVA analysis, differences between individual group means were analyzed by the Bonferroni post-hoc test. The Student t-test was used to compare two independent groups. 
